BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3046347)

  • 1. Sensitivity and specificity of three methods of detecting adverse drug reactions.
    Berry LL; Segal R; Sherrin TP; Fudge KA
    Am J Hosp Pharm; 1988 Jul; 45(7):1534-9. PubMed ID: 3046347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic risk-assessment model for identifying patients with adverse drug reactions.
    Tschepik W; Segal R; Sherrin TP; Schneider DN; Hammond RL
    Am J Hosp Pharm; 1990 Feb; 47(2):330-4. PubMed ID: 2309721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of standardized screening procedures to identify adverse drug reactions.
    Koch KE
    Am J Hosp Pharm; 1990 Jun; 47(6):1314-20. PubMed ID: 2368724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidisciplinary program for detecting and evaluating adverse drug reactions.
    Keith MR; Bellanger-McCleery RA; Fuchs JE
    Am J Hosp Pharm; 1989 Sep; 46(9):1809-12. PubMed ID: 2801715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved reporting of adverse drug reactions.
    Kimelblatt BJ; Young SH; Heywood PM; Mandala AR; Gendelman S; Mehl B
    Am J Hosp Pharm; 1988 May; 45(5):1086-9. PubMed ID: 3400650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. System for voluntary reporting of adverse drug reactions in a university hospital.
    Vorce-West TE; Barstow L; Butcher B
    Am J Hosp Pharm; 1989 Nov; 46(11):2300-3. PubMed ID: 2589347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley.
    Jha N; Bajracharya O; Namgyal T
    Kathmandu Univ Med J (KUMJ); 2007; 5(4):504-10. PubMed ID: 18604084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the positive predictive values of antidote signals to detect potential adverse drug reactions (ADRs) in the medical intensive care unit (ICU).
    Kane-Gill SL; Bellamy CJ; Verrico MM; Handler SM; Weber RJ
    Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1185-91. PubMed ID: 19728294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacy-coordinated program that encourages physician reporting of adverse drug reactions.
    Gilroy GW; Scollins MJ; Gay CA; Harry DJ; Giannuzzi DF
    Am J Hosp Pharm; 1990 Jun; 47(6):1327-33. PubMed ID: 2368726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Program coordinated by a drug information service to improve adverse drug reaction reporting in a hospital.
    Michel DJ; Knodel LC
    Am J Hosp Pharm; 1986 Sep; 43(9):2202-5. PubMed ID: 3766573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidisciplinary adverse drug reaction surveillance program.
    Prosser TR; Kamysz PL
    Am J Hosp Pharm; 1990 Jun; 47(6):1334-9. PubMed ID: 2368727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A quantitative approach of using genetic algorithm in designing a probability scoring system of an adverse drug reaction assessment system.
    Koh Y; Yap CW; Li SC
    Int J Med Inform; 2008 Jun; 77(6):421-30. PubMed ID: 17921048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of three algorithms used to evaluate adverse drug reactions.
    Michel DJ; Knodel LC
    Am J Hosp Pharm; 1986 Jul; 43(7):1709-14. PubMed ID: 3752106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of adverse drug reactions in adult medical inpatients.
    Bowman L; Carlstedt BC; Black CD
    Can J Hosp Pharm; 1994 Oct; 47(5):209-16. PubMed ID: 10172139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug reactions: the San Juan Department of Veterans Affairs Medical Center experience.
    Nazario M; Feliú JF; Rivera GC
    Hosp Pharm; 1994 Mar; 29(3):244-6, 249-50. PubMed ID: 10171808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a database computer program to identify trends in reporting of adverse drug reactions.
    Johnston PE; Morrow JD; Branch RA
    Am J Hosp Pharm; 1990 Jun; 47(6):1321-7. PubMed ID: 2368725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug reaction monitoring: comparing doctor and patient reporting for new drugs.
    Jarernsiripornkul N; Kakaew W; Loalukkana W; Krska J
    Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):240-5. PubMed ID: 19148880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a videotape on adverse drug reactions.
    Morgan SA; Frank JT
    Am J Hosp Pharm; 1990 Jun; 47(6):1340-2. PubMed ID: 1695062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of the capture-recapture method to assess the frequency of "serious" adverse drug reactions: experience of Toulouse University Hospital].
    Montastruc JL; Lugardon S; Desboeuf K; Fernet P; Lapeyre-Mestre M
    Bull Acad Natl Med; 2008 Feb; 192(2):421-30; discussion 430-1. PubMed ID: 18819693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of an indirect method of detecting adverse reactions to anticoagulants.
    Swanson CN; Keys PW
    Am J Hosp Pharm; 1987 Mar; 44(3):544-8. PubMed ID: 3565412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.